We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
+$1.01B
Cap. Flow
+$589M
Cap. Flow %
4.3%
Top 10 Hldgs %
11.63%
Holding
1,581
New
640
Increased
361
Reduced
263
Closed
311

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.4M
2
PFE icon
Pfizer
PFE
+$82.7M
3
MCD icon
McDonald's
MCD
+$65.4M
4
KDP icon
Keurig Dr Pepper
KDP
+$64.6M
5
ULTA icon
Ulta Beauty
ULTA
+$63.9M

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$225M
2
AMZN icon
Amazon
AMZN
+$144M
3
BCR
CR Bard Inc.
BCR
+$135M
4
ZTS icon
Zoetis
ZTS
+$121M
5
MJN
Mead Johnson Nutrition Company
MJN
+$120M

Sector Composition

Rank Sector Weight
1 Healthcare 20.96%
2 Technology 16.17%
3 Consumer Discretionary 15.54%
4 Industrials 10.23%
5 Financials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HNI icon
1051
HNI Corp
HNI
$3.49B
$620K ﹤0.01%
+15,505
New +$676K
TLGT
1052
DELISTED
Teligent, Inc
TLGT
$619K ﹤0.01%
+6,873
New +$585K
CLS icon
1053
Celestica
CLS
$42.7B
$616K ﹤0.01%
+43,979
New +$617K
LILA icon
1054
Liberty Latin America Class A
LILA
$1.69B
$616K ﹤0.01%
+43,743
New +$599K
EEFT icon
1055
Euronet Worldwide
EEFT
$2.93B
$613K ﹤0.01%
7,042
-206,647
-97% -$17.7M
INSY
1056
DELISTED
Insys Therapeutics, Inc.
INSY
$612K ﹤0.01%
+47,096
New +$557K
ATEN icon
1057
A10 Networks
ATEN
$2.21B
$609K ﹤0.01%
76,107
+7,681
+11% +$65.2K
CCRN
1058
DELISTED
Cross Country Healthcare
CCRN
$603K ﹤0.01%
46,393
+15,987
+53% +$206K
TWX
1059
DELISTED
Time Warner Inc
TWX
$603K ﹤0.01%
6,031
-229,081
-97% -$22.7M
ZVO
1060
DELISTED
Zovio Inc. Common Stock
ZVO
$601K ﹤0.01%
+40,034
New +$538K
LDL
1061
DELISTED
Lydall, Inc.
LDL
$596K ﹤0.01%
+11,455
New +$590K
NVRI icon
1062
Enviri
NVRI
$671M
$594K ﹤0.01%
+37,141
New +$536K
VOD icon
1063
Vodafone
VOD
$36.3B
$591K ﹤0.01%
+20,381
New +$567K
SCM icon
1064
Stellus Capital Investment Corp
SCM
$233M
$589K ﹤0.01%
42,070
+24,514
+140% +$343K
CULP icon
1065
Culp Inc
CULP
$43.7M
$587K ﹤0.01%
+17,802
New +$575K
VRTS icon
1066
Virtus Investment Partners
VRTS
$1.11B
$579K ﹤0.01%
+5,217
New +$553K
VECO icon
1067
Veeco
VECO
$3.28B
$577K ﹤0.01%
+20,605
New +$633K
TPVG icon
1068
TriplePoint Venture Growth BDC
TPVG
$193M
$565K ﹤0.01%
+43,462
New +$593K
OMED
1069
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$561K ﹤0.01%
+187,088
New +$776K
LPNT
1070
DELISTED
LifePoint Health, Inc.
LPNT
$558K ﹤0.01%
+8,331
New +$527K
EXTN
1071
DELISTED
Exterran Corporation
EXTN
$552K ﹤0.01%
20,432
-79,106
-79% -$2.24M
HTZ
1072
DELISTED
Hertz Global Holdings, Inc.
HTZ
$552K ﹤0.01%
+52,929
New +$569K
RILY icon
1073
BRC Group Holdings
RILY
$308M
$550K ﹤0.01%
+28,954
New +$443K
CCS icon
1074
Century Communities
CCS
$2B
$548K ﹤0.01%
+21,919
New +$566K
HBI
1075
DELISTED
Hanesbrands
HBI
$548K ﹤0.01%
+23,816
New +$514K
41 42
43
44 45

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2017 Portfolio in Review

As of Q2 2017, Marshall Wace North America held 1,581 positions worth $13.7B, up 8% from $12.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace North America deployed $589M of net new capital in Q2 2017, opening 640 new positions and adding to 361 existing holdings. Its largest new stake was Ulta Beauty: 218,927 shares worth $62.8M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was T-Mobile US, an estimated $225M trimmed.

  • Marshall Wace North America's largest Q2 2017 buy was Ulta Beauty: 218,927 shares worth $62.8M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q2 2017, an estimated $90.4M increase.
  • Marshall Wace North America's biggest Q2 2017 reduction was T-Mobile US, cutting an estimated $225M.
  • Marshall Wace North America fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 12% of its $13.7B portfolio in Q2 2017.
  • Marshall Wace North America opened 640 new positions and closed 311 in Q2 2017.
  • Marshall Wace North America's portfolio value rose 8% quarter-over-quarter to $13.7B.

Based on Marshall Wace North America's 13F filing for Q2 2017, filed 4 Aug 2017.